Beckman Coulter Life Sciences appoints Suzanne Foster as President

Beckman Coulter Australia

Wednesday, 10 August, 2022

Beckman Coulter Life Sciences appoints Suzanne Foster as President

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, recently announced that Suzanne Foster has been appointed as President of the company. Foster joins Beckman Coulter Life Sciences from Cardinal Health, where she spent the past two years serving as President of the Health-at-Home business.

A seasoned executive, Foster brings more than 25 years of experience in the healthcare industry. She has previously served as President of Healthcare at Stanley Black & Decker, where her leadership style and commitment to innovation substantially grew the business. Her robust career also includes 10 years at Medtronic as General Manager of their Advanced Energy business.

“The legacy and mission of Beckman Coulter Life Sciences, along with the commitment to customers and innovation, resonated with me long ago,” Foster said. “As I meet with customers, I hear firsthand how important it is for us to continue developing automation solutions to help labs increase speed, reduce errors and deliver advanced analytics. We will continue our relentless pursuit to be the trusted and preferred partner to help labs answer important scientific questions and overcome healthcare challenges.”

Foster holds an MPH in Law and Health Policy from Harvard University, a JD from Suffolk University, an MEd in Psychology from Notre Dame College and a BA in Communication from the University of New Hampshire. She started her career as a clinical social worker for an in-patient psychiatric unit, went on to law school and practised health law before she moved into chief operating roles.

“At every level, I’ve seen the need for efficient and timely testing and research solutions,” Foster said. “We will continue to lead the way with pioneering new technologies that can help laboratories of all sizes achieve these goals and bring down costs. It excites me to know that our instruments are helping labs around the world with their next big breakthrough and improving the lives of patients, while easing the manual workload on staff.”

Headquartered in Indiana, USA, Beckman Coulter Life Sciences has a substantial global footprint which includes 11 large operational facilities, more than 3300 associates and more than 300,000 Beckman Coulter Life Sciences systems installed globally. The company’s outgoing President, Greg Milosevich, has taken a new position in the life sciences companies of Danaher Corporation, of which Beckman Coulter Life Sciences is also a member.

Pictured: Suzanne Foster.

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

Fellowships and scholarships support women in science

The L'Oréal-UNESCO For Women in Science initiative has honoured five trailblazing...

2024 GSK Award recognises neurodegeneration researcher

Professor Matthew Kiernan won the 2024 GSK Award for Research Excellence for his work in...

ACCC concerned by Blackstone's proposed acquisition of I'rom

The ACCC is concerned that the proposed acquisition would likely have the effect of substantially...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd